This inventor holds 1 USPTO granted patent. Top assignee: Ligand Pharmaceuticals, Inc.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Richard J Penulian: Innovator in Thrombopoietin Modulation
Introduction
Richard J Penulian is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of thrombopoietin activity. His innovative work has the potential to impact treatments for various diseases.
Latest Patents
Richard J Penulian holds a patent for "Thrombopoietin activity modulating compounds and methods." This patent discloses compounds of Formula (I), (II), and (III), along with pharmaceutical compositions comprising these compounds. The methods outlined in the patent include modulating the activity of a thrombopoietin receptor, identifying compounds as thrombopoietin receptor modulators, and treating diseases by administering the compounds to patients in need. He has 1 patent to his name.
Career Highlights
Penulian is currently associated with Ligand Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at Ligand Pharmaceuticals focuses on innovative solutions in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Jyun-Hung Chen and E Adam Kallel, who contribute to the collaborative efforts in their research projects.
Conclusion
Richard J Penulian is a distinguished inventor whose work in thrombopoietin modulation showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic approaches in treating diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile